0      0

30th Annual North American Cystic Fibrosis Conference

W07: NT: Clinical Advances in Cystic Fibrosis Research

Oct 27, 2016 9:45am ‐ Oct 27, 2016 11:05am

Standard: $49.99


This session will present new data from recent clinical research in cystic fibrosis. Presentations will include assessment of measures of disease progression, new data on the effects of CFTR potentiators and correctors in younger patients and over longer time spans, and studies of the correlation between in vitro and in vivo responses to CFTR potentiators.

Educational Objectives:
  • Compare outcome parameters and clinical trials results in infants and preschool children.
  • Analyze the impact of CFTR modifiers in younger patients and over longer time spans.
  • Examine the correlation between ex vivo and in vivo drug benefit.

*** This session was streamed live during the 2016 NACFC. To watch free archived versions of the live streamed sessions, register here: https://arc.nacfconference.org/cff/live/16



  • John P. Clancy, M.D., Senior Director, Clinical Trials, Cincinnati Children`s Hospital Medical Center



You must be logged in and own this session in order to post comments.